| Literature DB >> 32138368 |
Dorina Lauritano1, Giulia Moreo1, Alberta Lucchese2, Chiara Viganoni1, Luisa Limongelli3, Francesco Carinci4.
Abstract
INTRODUCTION: Osseointegration are often suffering from oral conditions, especially, the micro gap at the implant-abutment connection represents a site for bacterial plaque aggregation, leading to increased inflammatory cells and causing peri-implantitis. AIM: The aim of this narrative review was to describe the different kinds of implant-abutment connections and their ability to reduce bacterial leakage and thus prevent peri-implantitis.Entities:
Keywords: dental abutments; dental implant-abutment design; dental implantation; dental implants; immediate dental implant loading; peri-implantitis; periodontics
Year: 2020 PMID: 32138368 PMCID: PMC7085009 DOI: 10.3390/ma13051131
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Inclusion and exclusion criteria.
| Inclusion Criteria | Exclusion Criteria |
|---|---|
| In vivo and in vitro studies | No clear reference to the relationship between implant-abutment-connection (IAC) and bacterial leakage |
| Prospective and retrospective studies | Case report because of limited clinical relevance |
| Systematic and narrative reviews | Studied with less than fifteen implants as sample size |
| Less than 48 h of follow-up for in vitro studies | |
| Less than 14 days of follow-up for in vivo studies |
Characteristic of implants included in the study and follow-up periods.
| Authors, Year | Type of Study | N° Implant Included | Type of Implant | Type of Connection | Follow Up |
|---|---|---|---|---|---|
| Gherlone, 2015 | In vitro | 80 | Sweden and Martina | DAT connection—double action tight (internal connection) | 96 h |
| Enkling, 2013 | Rand. clinical trial | 25 | SICace, SIC-Invent AG | Internal hexagonical | 3 years |
| Cassetta, 2015 | Prospect. cohort study | 748 | Impladent | Platform-switching | 3 years |
| Bassi, 2016 | Prospect. clinical study | 52 | Elisir cylindrical, Elisir EVO conical | Internal hexagonical | 4 years |
| Lopez, 2016 | Retrospect. study | 66 | I-Fix | External Hex, Deep Conical, Internal Octagon, Internal Hex, Conical Connection | 40 m |
| Garrana, 2016 | In vitro | 27 | Southern Implants, Neodent, Straumann, Dentsply-Ankylos | External Hex, Deep Conical, Internal Octagon, Internal Hex, Conical Connection | 7 days |
| Canullo, 2015 | Cross-sectional study | 40 | BIOMET 3i, Sweden and Martina, ASTRA TECH Implant System | Double internal hexagon, internal hexagon, conical connection | 5 years |
| Costa, 2017 | In vitro case-control | 24 | Intraoss | External hexagonal | 14 days |
| Arshad, 2017 | In vitro case-control | 20 | Dentium | NR | 1 m |
| Siadat, 2016 | In vitro case-control | 17 | Nobel Biocare | NR | 12 days |
| Romanos, 2014 | Case-control | 240 | Dentsply Implants, Biomet 3i | Platform-switching, Morse tapered, internal polygonal butt-joint | 2 years |
| Scarano, 2016 | Clinical trial | 146 | Dental Tech | NR | NR |
| Ugurel, 2013 | Case-control | 64 | Tasarimmed, Straumann, Biohorizons, Dentsply friadent | Screwless Morse taper | NR |
| Lauritano, 2017 | In vitro case-control | 40 | Edierre Implants System | NR | 96 h |
| Andreasi Bassi, 2016 | Prospect. clinical study | 133 | EVO | Tapered connection | NR |
| Lopez, 2016 | Retrospect. clinical study | 215 | Falappa Medical Devices | Conical connection | 5 years |
| Carinci, 2016 | In vitro case-control | 17 | Implant System FMD | FN, NQ, Eisir by FMD, Rome, Italy | 48 h |
| Mencio, 2017 | Rand. clinical trial | 20 | NR | Cemented implant-abutment and screwed implant-abutment connection | 1 year |
| Gehrke, 2016 | Case-control | 40 | NR | Conical internal connection | NR |
| Sesma, 2016 | Case-control | 36 | Conexão (Conect AR) | Platform-switched and platform matched | 15 m |
| Nayak, 2016 | In vitro case-control | 45 | ADIN DentalImplant System | NR | 48 h |
| Mencio, 2016 | In vitro case-control | 15 | Winsix, BioSAF IN | NR | 14 days |
Exclusion criteria, confounding factors and limitations of the included studies.
| Summary of Exclusion Criteria | Summary of Confounding Factors | Summary of Limitation of the Studies | Type of Analysis (In Vivo Studies) | Type of Analysis (In Vitro Studies) |
|---|---|---|---|---|
| Alcohol | Not clear best torque value | Short follow-up | Bone loss valued with periapical radiograph | Microbiological exam: PCR, culture exam, limulus, amoebocyte lysate * |
NR = not reported. * Bacteria analyzed: Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola, Prevotella intermedia, Micromonas micros, Fusobacterium nucleatum, Campylobacter rectus, Eikenella corrodens and Candida albicans.
Figure 1PRISMA Flow Diagram.
Results of individual studies.
| Study | Implant Connection | Outcome Measure | Results |
|---|---|---|---|
| Gherlone, 2015 | Internal conical connection (ICC) | % of contaminated implants | ICC = 30% |
| Sesma, 2016 | Platform switching connection (PSC) | Vertical bone change one year after functional loading | 0.40 ± 0.19 |
| Cassetta, 2016 | Platform switching connection (PSC) | Mean marginal bone remodeling | −0.56 mm |
| Enkling, 2013 | Platform switching connection (PSC) | Mean radiographic peri-implant bone loss | PSC = 0.69 ± 0.43 mm |
| Cannullo, 2015 | Conical connection (CC) vs. double internal hexagon connections (DIHC) | Positivity to red complex bacteria | CC = 10% |
| Lauritano, 2017 | Antimicrobial polysiloxane coating on the implant-abutment junction (PCJ) vs cemented implant-abutment connection (CC) | Total bacterial count on average | PCJ = 3.7E + 08 |
| Carinci, 2016 | Internal conical connection design: nano fix vs. uNiQo vs. Elisir implant systems by FMD, Rome, Italy | Median percentage of bacteria living in the inner side of the implants | uNiQo = 1.4% |